Cita APA

Moreno, S., Rivero Román, A., Ventayol, P., Torralba, M., Schroeder, M., & Falcó, V. (2023). Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain.

Citación estilo Chicago

Moreno, Santiago, Antonio Rivero Román, Pere Ventayol, Miguel Torralba, Melanie Schroeder, y Vicenç Falcó. Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months Is Cost-Effective for the Treatment of HIV-1 in Spain. 2023.

Cita MLA

Moreno, Santiago, et al. Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months Is Cost-Effective for the Treatment of HIV-1 in Spain. 2023.